Tart R C, McDaniel L S, Ralph B A, Briles D E
Department of Microbiology, University of Alabama at Birmingham 35294-2170, USA.
J Infect Dis. 1996 Feb;173(2):380-6. doi: 10.1093/infdis/173.2.380.
Immunization with pneumococcal surface protein A (PspA) from Streptococcus pneumoniae strain Rx1 cross-protects mice against challenge with diverse pneumococci. Truncated Rx1 PspA, consisting of amino acids 192-588, elicits protection against the mouse-virulent strain WU2. The possibility that homologous regions of other PspAs could also elicit cross-protection was investigated. Oligonucleotide primers designed according to the Rx1 pspA gene sequence were used to amplify chromosomal DNA from 15 diverse pneumococci. Three recombinant PspAs were evaluated for their ability to elicit protection in mice against challenge with 7 strains representing capsular types 3, 4, 5, 6A, and 6B. Two of the three truncated PspAs each elicited cross-protection against 71%-100% of the S. pneumoniae challenge strains examined. These data suggest that this technique may be useful for the generation of diverse PspAs for inclusion in a broadly protective pneumococcal vaccine.
用肺炎链球菌Rx1菌株的肺炎球菌表面蛋白A(PspA)免疫小鼠,可使其免受多种肺炎球菌攻击的交叉保护。由氨基酸192 - 588组成的截短型Rx1 PspA可诱导对小鼠高毒力菌株WU2的保护作用。研究了其他PspA同源区域是否也能诱导交叉保护的可能性。根据Rx1 pspA基因序列设计的寡核苷酸引物用于扩增15种不同肺炎球菌的染色体DNA。评估了三种重组PspA诱导小鼠对代表3、4、5、6A和6B荚膜型的7种菌株攻击产生保护的能力。三种截短型PspA中的两种分别对71% - 100%检测的肺炎链球菌攻击菌株诱导了交叉保护。这些数据表明,该技术可能有助于生成多种PspA,以纳入具有广泛保护作用的肺炎球菌疫苗中。